-
SpyGlass Pharma (SGP) said on Thursday that it will acquire Advanced Vision Science for about $13M in cash.
-
Advanced Vision Science, a wholly owned subsidiary of Santen Pharmaceutical (SNPHF), is an ophthalmic medical device company and manufacturer of intraocular lenses and lens materials.
- Under the agreement, AVS will be the exclusive manufacturer and supplier of several types of IOLs to Santen for commercialization in Japan.
- Press Release
SpyGlass Pharma acquires Advanced Vision Science (SGP:NASDAQ)
